KLYG Receives FDA Clearance To Market Cranial Implant (KLYG)

Kelyniam Global (KLYG) an emerging medical device manufacturer, announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Patient Specific Custom Cranial Implants.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!